About Swaasa
Swaasa is a Healthcare company based in Hyderabad (India) founded in 2017 by Narayana Rao Sripada. Respiratory health diagnosis is enabled by AI-based cough analysis. Its chief executive, as recorded, is Venkat Yechuri. Its Indian entity Salcit Technologies Private Limited reported revenue of ₹83.6 Lakh. Swaasa offers products and services including Lung Assessment Test and Swaasa Platform. Its focus areas include HealthTech, Healthcare IT, Provider and Clinical Operations. Its competitors include Docturnal and Ibrum Technologies; 1 of its 2 listed competitors has raised funding.
Company details
Swaasa was founded in 2017 in Hyderabad, India, within the health technology sector. An AI-driven tool is provided to healthcare providers for respiratory health assessments. Cough sounds are analyzed to support patient diagnoses, with data generated on temperature, oxygen saturation levels, and lung conditions. Operations focus on software integration for clinical use in respiratory care.
- Headquarters Hyderabad, India
- Founders Narayana Rao Sripada
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website swaasa.ai
- Social LinkedIn X Facebook
- Legal Name Salcit Technologies Private Limited
- Date of Incorporation 01 Sep, 2017
- Jurisdiction Hyderabad, Telangana, India
- Annual Revenue₹83.6 Lakh
FY 2025 · -10% YoY
- Net Loss-₹17 Lakh
FY 2025 · -20% margin
- EBITDA-₹14.4 Lakh
FY 2025 · -17% margin
- Investors
Associated legal entities of Swaasa
Swaasa operates through Salcit Technologies Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Salcit Technologies Private Limited CIN U72501TG2017PTC119237 | Active | 01 Sep 2017 | Hyderabad, Telangana | ₹0.8 Cr | 3 | View details |
Products & Services of Swaasa
Swaasa offers a comprehensive portfolio of products and services, including Lung Assessment Test and Swaasa Platform.
Quick AI-based test for evaluating lung health via cough sounds.
Platform for machine learning-driven respiratory assessments and data security.
Funding Insights of Swaasa
- Total Rounds 1
- Investors Count 1
All 1 funding rounds of Swaasa with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2021 | Seed | – | T-Hub | – |
1 investors in total: 1 institutional.
Investors in Swaasa
Swaasa has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include T-Hub.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Innovation hub connecting startups, corporates, and partners in technology and ecosystem development. | 2015 | t-hub.co | Hyderabad, India |
Investor details for Swaasa
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Salcit Technologies Private Limited (Swaasa)
Salcit Technologies Private Limited is the primary company behind Swaasa. The board of Salcit Technologies Private Limited currently have 3 directors; the longest-serving is Sripada Venkata Naga Narayana Rao, appointed in 2017. 2 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Sripada Venkata Naga Narayana Rao DIN 02213948 | Director | 01 Sep 2017 | 9 yrs 1 mo | Salcit Technologies Private Limited |
| Padma Shayi Yarlagadda DIN 07925867 | Director | 01 Sep 2017 | 9 yrs 1 mo | Salcit Technologies Private Limited |
| Nagalalita Tangirala DIN 01790369 | Director | 12 Jun 2024 | 2 yrs 4 mo | Salcit Technologies Private Limited |
People of Swaasa
2 people are tracked at Swaasa (2 in leadership).
| Name | Role | Group |
|---|---|---|
| Founder & Director & CTO | Leadership | |
Venkat Yechuri | CEO | Leadership |
Complete people profiles for Swaasa
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Swaasa
Figures of Salcit Technologies Private Limited, the primary company behind Swaasa, for FY 2025. Revenue was ₹83.6 Lakh (-10% year on year). Net loss was -₹17 Lakh (-20% margin). EBITDA was -₹14.4 Lakh (-17% margin). Revenue has grown at a compounded annual rate of -4% over three years and +38% over five years.
- ₹83.6 LakhRevenue · FY 2025 · -10% YoY
- -₹17 LakhNet loss · -20% margin
- -₹14.4 LakhEBITDA · -17% margin
- ₹2 LakhPaid-up capital
- -4%Revenue CAGR, 3 years
- +38%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Salcit Technologies Private Limited are on its company page.
Detailed financial statements for Swaasa
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Swaasa
2 dated milestones of Swaasa across 4 years, from founding to its latest funding, stage changes and deals.
- Founded Swaasa is founded.
- Funding First funding round.
Competitors of Swaasa
Swaasa has 2 listed competitors in our database, 1 of them funded. They include Docturnal and Ibrum Technologies.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| docturnal.com | 2016 | Hyderabad, India | $92,308 | Non-invasive solutions for tuberculosis detection and diagnostics are provided. | ||
| ibrum.tech | 2015 | Bengaluru, India | Devices for detecting undiagnosed cardiac and respiratory diseases are developed. |
Detailed competitors of Swaasa
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Swaasa
The website of Swaasa (swaasa.ai) receives about 1.4K visits a month.
- Monthly visits1.4K
▼ 23.4% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Swaasa
Swaasa was founded in 2017 and raised its 1st funding round 4 years after it was founded.
Swaasa is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Venkat Yechuri is the CEO of Swaasa, as recorded in our data.
The primary company behind Swaasa, Salcit Technologies Private Limited, reported revenue of ₹83.6 Lakh for FY 2025, down 10% year on year.
Swaasa was founded in 2017 in Hyderabad, India, within the health technology sector. An AI-driven tool is provided to healthcare providers for respiratory health assessments. Cough sounds are analyzed to support patient diagnoses, with data generated on temperature, oxygen saturation levels, and lung conditions. Operations focus on software integration for clinical use in respiratory care.
Swaasa's top competitors include Docturnal and Ibrum Technologies.
Swaasa offers Lung Assessment Test and Swaasa Platform.
Swaasa has 1 investor. Key investors include T-Hub.
Swaasa operates through Salcit Technologies Private Limited.
The legal entities of Swaasa currently have 3 directors, including Nagalalita Tangirala, Sripada Venkata Naga Narayana Rao, Padma Shayi Yarlagadda.